What question did this study set out to answer?

The study aims to investigate how METTL3-mediated methylation of TNXB can prevent neural injury and cellular apoptosis following ischemic stroke.

April 15, 2026

Methylation of Tenascin XB mediated by Methyltransferase-like 3 can effectively suppress neural injury and cellular apoptosis induced by ischemic stroke

Key Points

The study aims to investigate how METTL3-mediated methylation of TNXB can prevent neural injury and cellular apoptosis following ischemic stroke.
Examined the role of METTL3 in methylating TNXB
Assessed the relationship between m6A methylation and cellular damage in neural cells exposed to ischemic conditions
Analyzed the potential therapeutic effects of targeting the METTL3-TNXB axis
METTL3 methylation stabilizes TNXB expression
Targeting this pathway reduces cellular damage caused by ischemic stroke
Lower levels of cellular apoptosis were observed when METTL3 is active

Abstract

METTL3 stabilizes TNXB expression through m6A methylation modification, thereby alleviating IS-induced cellular damage. This suggests that targeting the METTL3-TNXB axis may represent a potential therapeutic strategy for IS.

Bookmark

Methylation of Tenascin XB mediated by Methyltransferase-like 3 can effectively suppress neural injury and cellular apoptosis induced by ischemic stroke

Key Points

Abstract

Cite This Study

Also Consider

Also Consider